Türkiye’s Medical Tourism Footfall Is Shrinking — And 2025 Was the Sharpest Drop Yet
Official figures published by Uluslararası Sağlık Hizmetleri A.Ş. (USHAŞ) (sourced from Türkiye İstatistik Kurumu / TurkStat) point to a trend the industry would rather not discuss: fewer people are coming to Türkiye for medical tourism—and the decline is accelerating.
The numbers: down two years in a row
USHAŞ reports the following counts for visitors who came to Türkiye specifically to receive health services:
- 2023: 1,538,643
- 2024: 1,506,442 (-2.23% YoY)
- 2025: 1,398,580 (-9.16% YoY)
That’s a -12.10% decrease from 2023 to 2025—about 140,063 fewer medical-tourism visitors in just two years.
This isn’t a one-off fluctuation. It’s two consecutive declines, with the drop worsening in 2025.

“Stable revenue” may be masking weakness, not proving strength
USHAŞ also reports medical tourism revenue (in thousand USD) as:
- 2023: 3,006,092
- 2024: 3,022,957
- 2025: 3,022,452
On paper, revenue looks steady. But paired with falling visitor numbers, it supports a far less flattering interpretation: Türkiye may be depending on fewer, higher-spending cases (or inflation-driven pricing) rather than broad-based demand strength.
A second, self-inflicted problem: rising costs and a licensing bottleneck
Beyond demand, the sector is also facing growing complaints about costly compliance and a slow-moving authorization pipeline for hospitals and medical tourism intermediaries (“aracı kuruluş”). Industry voices argue the process has become burdensome, and in practice can stretch into many months—sometimes described as exceeding a year—even if the formal rules describe a faster administrative timeline.
The flashpoint: mandatory HealthTürkiye Portal membership fee jump
A major controversy has been the mandatory HealthTürkiye Portal annual membership fee, required for medical tourism providers and intermediaries to obtain/maintain authorization. TÜRSAB publicly stated the fee was raised from 26,000 TL to 120,000 TL and announced it filed a legal action seeking cancellation of the increase. (tursab.org.tr)
That change has been framed by sector commentators as a pure cost burden—“mandatory membership with limited practical return”—especially for intermediaries who must pay it regardless of volume. (Instagram)
Why this matters?
For a destination that sells itself on “scale” and “momentum,” falling patient volume plus rising entry/operating costs is a dangerous combination. If 2026 continues this direction, the industry’s talking points will start to sound like spin—particularly for operators living on high-volume funnels and referrals.
At minimum, the data and the regulatory backlash should force tougher questions:
- Is Türkiye losing price-sensitive medical tourists to competing destinations?
- Are higher costs and administrative friction pushing smaller providers out—or underground?
- Is the system rewarding a narrower set of large players while the overall market shrinks?
The official statistics don’t explain why demand is dropping. But they do confirm the uncomfortable bottom line: Türkiye attracted fewer medical-tourism visitors in 2024—and even fewer in 2025.